Company Filing History:
Years Active: 2021-2022
Title: Rumin Wang: Innovator in ErbB/BTK Inhibitors
Introduction
Rumin Wang is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit ErbB and BTK proteins. With a total of 2 patents, her work is paving the way for new treatments for various diseases, including cancer.
Latest Patents
Rumin Wang's latest patents focus on ErbB/BTK inhibitors. These patents disclose compounds that inhibit ErbBs, such as EGFR or Her 2, especially their mutant forms, along with BTK. The patents also cover pharmaceutically acceptable salts, hydrates, solvates, or stereoisomers of these compounds, as well as pharmaceutical compositions that include them. The compounds and compositions are designed to effectively treat diseases associated with ErbBs and BTK, particularly cancer.
Career Highlights
Throughout her career, Rumin Wang has worked with notable companies in the pharmaceutical industry. She has been associated with Dizal Pharmaceutical Co., Ltd. and Dizal Pharmaceutical Co., Limited. Her expertise in the field has allowed her to contribute to significant advancements in drug development.
Collaborations
Rumin Wang has collaborated with several professionals in her field, including Zhengtao Li and Hao Zou. These collaborations have further enhanced her research and development efforts in the pharmaceutical sector.
Conclusion
Rumin Wang is a key figure in the development of innovative treatments for diseases associated with ErbB and BTK. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.